| Journal of Clinical Gynecology and Obstetrics, ISSN 1927-1271 print, 1927-128X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Gynecol Obstet and Elmer Press Inc |
| Journal website https://jcgo.elmerpub.com |
Review
Volume 000, Number 000, November 2026, pages 000-000
The Endometrial–Vaginal Microbiota Axis as a Determinant of Implantation and Live Birth Outcomes in Assisted Reproductive Technology
Figures


Tables
| CST | Dominant species | Metabolic & biochemical profile | Immunological state | Impact on ART outcomes |
|---|---|---|---|---|
| ART: assisted reproductive technology; CSTs: community state types; IL-6: interleukin-6; RIF: recurrent implantation failure; TNF-α: tumor necrosis factor-alpha. | ||||
| CST I | Lactobacillus crispatus | High lactic acid production, significant hydrogen peroxide (H2O2) and bacteriocin synthesis; maintains strict acidic pH (∼4.0). | Highly tolerogenic mucosal environment; suppresses pro-inflammatory cytokines; robust barrier integrity. | Highly favorable: Strongly associated with the highest implantation, clinical pregnancy, and live birth rates. |
| CST II | Lactobacillus gasseri | Moderate lactic acid and H2O2 production; stable acidic pH maintenance. | Tolerogenic; limits opportunistic pathogen adherence and epithelial invasion. | Favorable: Supports healthy embryo-maternal dialogue and successful implantation, though slightly less robust than CST I. |
| CST III | Lactobacillus iners | Variable lactic acid production; often lacks H2O2 synthesis; prone to pH fluctuations. | Transitional state; can shift toward inflammation under stress or hormonal shifts. | Intermediate/vulnerable: Often observed in transitional states prior to dysbiosis; associated with less predictable ART outcomes. |
| CST V | Lactobacillus jensenii | Effective lactic acid production; provides consistent competitive exclusion against pathogens. | Tolerogenic; supports stable mucosal immunity. | Favorable: Comparable to CST II; supports optimal endometrial receptivity and ongoing pregnancy. |
| CST IV | Polymicrobial dysbiosis (e.g., Gardnerella, Atopobium, Prevotella, Sneathia) | Elevated pH (> 4.5); reduced lactic acid; increased production of volatile amines and local endotoxins. | Pro-inflammatory; disruption of epithelial tight junctions; recruitment of Th1/Th17 cells; elevated IL-6 and TNF-α. | Highly unfavorable: Directly linked to RIF, biochemical pregnancy, and early pregnancy loss. |
| Microbiota profile | Primary commensals/pathogens | Immunological & cellular impact | Impact on endometrial receptivity & ART |
|---|---|---|---|
| ART: assisted reproductive technology; IFN-γ: interferon-gamma; IL-6: interleukin-6; IL-17: interleukin-17; LIF: leukemia inhibitory factor; TNF-α: tumor necrosis factor-alpha. | |||
| Eubiotic (Lactobacillus-dominant) | L. crispatus, L. iners, L. jensenii | Maintains low pH via lactic acid; produces H2O2 and bacteriocins. Promotes tolerogenic mucosal environment and Treg expansion. | Supports embryo tolerance and optimal expression of receptivity markers; associated with higher live birth rates. |
| Dysbiotic (non-Lactobacillus) | Gardnerella, Atopobium, Prevotella, Streptococcus | Induces pro-inflammatory cytokines (IFN-γ, TNF-α, IL-6, IL-17); alters Th1/Th17 balance. Promotes biofilm formation. | Down-regulates receptivity genes (LIF, integrin ανβ3, HOXA10); disrupts epithelial barriers, leading to implantation failure or loss. |
| Biomarker concept/signature | Diagnostic niche | Primary diagnostic signal | Proposed clinical application in ART | Predictive accuracy & utility |
|---|---|---|---|---|
| ART: assisted reproductive technology; CST: community state type; LDM: Lactobacillus-dominant microbiota; NLDM: non-Lactobacillus-dominant microbiota; WGS: whole-genome sequencing. | ||||
| Endometrial LDM vs. NLDM | Endometrial fluid or biopsy (pre-transfer) | Eubiosis is defined as ≥ 90% Lactobacillus spp. (LDM). Dysbiosis (NLDM) is < 90% with > 10% pathogenic/opportunistic taxa. | Identification of hostile uterine microenvironments prior to embryo transfer; guides the use of targeted antibiotics for chronic endometritis. | Strong correlation with live birth probability; NLDM strongly predicts severe implantation failure and subsequent miscarriage. |
| Vaginal CST profiling | Vaginal swab (follicular phase or pre-stimulation) | Identification of CST I (optimal) versus CST IV (dysbiotic). | Non-invasive pre-cycle screening to stratify patients into high-chance versus low-chance prognostic categories. | High negative predictive value; effectively identifies patients at high risk of cycle failure due to ascending dysbiosis. |
| Multi-taxa predictive algorithms (e.g., “ReceptIVFity”) | Vaginal or cervical swab | Weighted ratio of favorable (L. crispatus) versus unfavorable (Gardnerella, Atopobium, L. iners) taxa. | Algorithmic risk stratification directing the decision to proceed with fresh embryo transfer or freeze-all and treat. | Validated models demonstrate up to a 94% negative predictive value for implantation failure in designated “low chance” groups. |
| Functional pathway biomarkers (metagenomic) | Genital tract fluid (WGS) | Presence of specific bacterial metabolic pathways (e.g., localized lipopolysaccharide synthesis vs. short-chain fatty acids). | Experimental; aims to move beyond taxonomy to measure the actual biochemical hostility of the reproductive tract. | Early-stage data; promises high precision by directly measuring the metabolic drivers of local mucosal inflammation. |
| Therapeutic strategy | Target/mechanism of action | Current evidence in ART | Key limitations & risks |
|---|---|---|---|
| ART: assisted reproductive technology; BV: bacterial vaginosis; CE: chronic endometritis; LD: Lactobacillus-dominant; NLD: non-Lactobacillus-dominant; VMT: vaginal microbiome transplantation. | |||
| Antibiotics | Broad-spectrum clearance of CE or BV. | Standard of care for CE; observational data shows improved implantation after histological resolution. | High recurrence rates for BV; risks microbiome disruption, collateral damage to Lactobacillus, and antimicrobial resistance. |
| Probiotics (oral/vaginal) | Shift communities toward Lactobacillus-dominance; restore acidic pH and suppress pathogens. | Moderate modulation shown; some case series report conversion from NLD to LD endometria. | High protocol heterogeneity; barrier of colonization resistance; inconsistent clinical pregnancy gains. |
| VMT | Transfer of vaginal fluid from healthy donor to resolve refractory dysbiosis. | Promising symptom resolution in small, non-ART BV series where antibiotics failed. | Experimental; requires stringent donor screening and long-term safety monitoring before ART application. |
| Study | Sample type | Technology | Primary outcome(s) | Key limitations |
|---|---|---|---|---|
| ART: assisted reproductive technology; LDM: Lactobacillus-dominant microbiota; NLDM: non-Lactobacillus-dominant microbiota; qPCR: quantitative polymerase chain reaction; WGS: whole-genome sequencing. | ||||
| Moreno et al, 2016 [21] | Endometrial fluid aspirate | 16S rRNA sequencing | LDM vs. NLDM: implantation 60.7% vs. 23.1%; live birth 58.8% vs. 6.7% | Small, single-center cohort; receptive-endometrium subgroup only |
| Moreno et al, 2021 [4] | Endometrial biopsy | 16S rRNA sequencing, multicenter | Lactobacillus enrichment associated with pregnancy; dysbiotic taxa predicted no pregnancy/miscarriage | Observational design; single pre-transfer sampling; causality not established |
| Koedooder et al (“ReceptIVFity”) [38, 39] | Vaginal swab | 16S rRNA + qPCR panel | 94% negative predictive value for implantation failure in “low-chance” profile | Predictive algorithm not yet externally validated in independent cohorts |
| Villani et al, 2022 [32] | Cervical swab | 16S rRNA (PELORA regression) | L. crispatus/salivarius/rhamnosus enrichment discriminated women who conceived | Cervical sampling may not reflect endometrial community |
| Polifke et al, 2024 [15] | Paired vaginal + endometrial biopsy | 16S rRNA sequencing | Endometrial and vaginal profiles differ; endometrium more diverse | Low endometrial biomass; high contamination risk |
| Chen et al, 2017 [8] | Vaginal, cervical, upper-tract (multi-site) | 16S rRNA sequencing | Demonstrated microbial continuum along the reproductive tract | Not ART-outcome focused; cross-sectional |
| Behrendt-Møller et al, 2025 [36] | Vaginal and rectal samples | Shotgun metagenomics (WGS), ≥ 30 million reads/sample | Taxa linked to pregnancy and live birth outcomes | Conference abstract with limited methodological and outcome detail |